ABPI responds to PM’s Brexit comments
The ABPI has responded to the Prime Minister’s comments on the possibility of a ‘no deal’ Brexit. The Prime … read more »
Guidance issued for post-Transition Period supply of medicines to NI
As the end of the Transition Period nears, the Department of Health and Social Care (DHSC) has issued advice on … read more »
UK and EU pharmaceutical industry jointly urges protection of medicines before Brexit transition period ends
As the deadline for Brexit negotiations approaches, the UK and EU pharmaceutical industry trade bodies, the Association of the British … read more »
MHRA launches Brexit guidance
The Medicines and Healthcare Products Regulatory Agency (MHRA) has released a raft of documents, with more to follow, explaining the … read more »
Government publishes guidance on moving goods under the Northern Ireland Protocol
The Government has published guidance for businesses on moving goods to and from Northern Ireland under the Northern Ireland Protocol … read more »
DHSC sends Brexit notice to companies
The Department of Health and Social Care (DHSC) has sent a letter to medicines and medical device companies to give … read more »
Consultation on future UK border arrangements
The UK Government has launched a consultation to establish opinions on designing a new border approach following the country’s departure … read more »
Industry bodies call for UK-EU MRA
Influential European industry groups have written to the three European Presidents, the Commissioner for Trade, and the Chief Negotiator for … read more »
HSC Committee responds to request on EU Brexit negotiating mandate
The European Scrutiny Committee has requested the views of all Select Committees on the EU-UK future relationship negotiating mandate laid … read more »
EMA statement clarifies Brexit situation
The European Medicines Agency (EMA) has released a statement to mark the start of the transition period between the UK … read more »
